missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PLAC1 Polyclonal Antibody
Description
A suggested positive control is human placenta lysate. PA5-21044 can be used with blocking peptide PEP-1158.
PLAC1 was initially identified as a protein expressed specifically in the placenta and other cells derived from the trophoblast lineage during embryonic development, but has also been found to be expressed ectopically in a wide range of human malignancies, particularly breast cancers. PLAC1 is a membrane-associated protein that is thought to serve a receptor-like function modulating cell-cell or ligand receptor interactions unique to the maternal-placental interface. Decreased expression of PLAC1 is associated with decreased expression of cyclin D1 and reduced expression of AKT kinase, which, combined with the fact that PLAC1 is expressed on the surface of cancer cells, suggests that PLAC1 may be an effective candidate for immunotherapeutic treatments of cancer.
Specifications
Specifications
| Antigen | PLAC1 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | PLAC1 |
| Gene Accession No. | Q9HBJ0 |
| Gene Alias | cancer/testis antigen 92; CT92; OOSP2L; PLAC1; placenta specific 1; placenta-specific 1; placenta-specific protein 1 |
| Gene Symbols | PLAC1 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?